Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$155.97 - $200.09 $384,466 - $493,221
-2,465 Closed
0 $0
Q1 2022

Apr 28, 2022

BUY
$181.39 - $234.03 $435,335 - $561,672
2,400 Added 3692.31%
2,465 $464,000
Q1 2021

Apr 22, 2021

BUY
$144.0 - $169.39 $9,360 - $11,010
65 New
65 $10,000
Q1 2020

May 12, 2020

SELL
$92.66 - $144.94 $404,924 - $633,387
-4,370 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$112.57 - $128.43 $491,930 - $561,239
4,370 New
4,370 $545,000
Q1 2019

May 13, 2019

SELL
$81.56 - $100.67 $422,480 - $521,470
-5,180 Closed
0 $0
Q2 2018

Aug 13, 2018

SELL
$79.9 - $89.2 $1,598 - $1,784
-20 Reduced 0.38%
5,180 $441,000
Q1 2018

May 14, 2018

SELL
$71.51 - $84.69 $7,151 - $8,469
-100 Reduced 1.89%
5,200 $434,000
Q4 2017

Feb 13, 2018

BUY
$63.24 - $72.8 $335,172 - $385,840
5,300
5,300 $382,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $76.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Hillsdale Investment Management Inc. Portfolio

Follow Hillsdale Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.